InvestorsHub Logo
Followers 4
Posts 398
Boards Moderated 0
Alias Born 06/21/2006

Re: rod5247 post# 3566

Friday, 10/17/2014 10:42:26 AM

Friday, October 17, 2014 10:42:26 AM

Post# of 9135
http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm133691.htm

Ig is approved for some demyelinating diseases and used off label now for certain forms of MS. It would be easy to expand hyqvia's indication into those Gammaguard already has approval for. What could be exciting would be if this new convenient form of Ig might make it now practical to use for the more common forms of MS. This indication would require trials but Baxter may have that in mind. And then, of course, is the possibility they might trial Hqvia in a subset of Alzheimer's.

It is possible that by the time Baxter has their Georgia plant up and running, and the Ig supply is no longer an issue, Hyqvia will have a few more indications...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News